Home News Weather Finance Travel Maps Movies Lottery Horoscopes Games
 SECTION: NEWS OF GREATER NEW YORK CITY
Search The Web:
DOMAIN NAMES
AS LOW AS $2.99 / YR.
Hormone Used To Treat Reperfusion Injury
Thursday, 08-May-2008 10:40AM United Press International
USTINET NEWS

 » Front Page

 » Top Stories

 » U.S. News

    Government

    Focus U.S.A.

    The White House

    U.S. Politics

    Social Issues

    Local Editions

 » World

 » Politics

 » Business

 » Sports

 » Health

 » Tech/Science

 » Living/Entertainment

 » Off Beat Stories

 » News Photos

 » Weather


Special Editions

 » Iraq & Conflict

 » Israel/Palestine

 » Crimes & Laws


MultiMedia

 » Interactive Features

 » News Photos


POLL: Your Opinion

 » What Do You Think




MANHASSET, N.Y., May 8 (UPI) -- U.S. scientists say they've used the hormone Ghrelin to block organ injury after intestinal ischemia-reperfusion, a common surgical problem.

SAVE MONEY ON TRAVEL DEALS

Dr. Ping Wang and colleagues at the Feinstein Institute for Medical Research used Ghrelin, which has potent anti-inflammatory properties, in laboratory models to test its effects on the events associated with oxygen deprivation in the gut. They found that it was successful in protecting against the abnormal inflammatory cascade that occurs when oxygen is restored to tissue.

During abdominal emergency surgery, there's a risk the blood supply to the intestine might be temporarily blocked, causing a potentially life-threatening problem, the researchers said. Once blood flow is restored, the reperfusion of oxygen triggers white blood cells to move into the area and releases molecules that can damage local tissue.

Wang's team using laboratory animals found Ghrelin decreased the abnormal inflammatory response by more than 50 percent, improved the function of the gut and reduced the intestinal bacterial count.

"Intestinal ischemia-reperfusion is a very critical condition, and there are no treatments", said Wang. "Hopefully, we can work towards developing this into an effective treatment for patients."

The study was published in the online journal PLoS One.

- - - - - - - - - - - - - - - - - - - -
Related News Topics:

General science stories
Top science, technical and computer stories
Miscellaneous News of New York State
News of Greater New York City
Miscellaneous science and technology stories
General science stories

 BREAKING STORIES

NYC comedy club owner sues scary partner

Nerve stimulation used to treat sepsis

Lightning strike hospitalizes three men

Pool safety spotlighted in arrest

Rival NYC tabloids consider deal

NYC: Most fireworks injuries of children

Ready cement halted in NYC strike

Report: Madonna, Ritchie dine out in NYC

Bon Jovi to play free NYC show

NYC seeks HIV-testing of all Bronx adults

Scientists ID new Alzheimer's disease gene

New drug may mitigate Alzheimer's disease

Bird mites victim released from hospital

26 percent of NYC has genital herpes

NYC crane inspector charged with bribes

Famous NYC restaurant settles EEOC suit

Hoof Specialist Changes Plan for Big Brown's Patch; Workout Set for Tuesday

Two die in NYC crane collapse

NYC judge sentences Remy Ma to 8 years in prison

NYC judge gives rapper Remy Ma 8 years in prison

Home News Weather Finance Travel Maps Movies Lottery Horoscopes Games
Home :: My Page :: My WebMail :: My Calendar :: My Portfolio :: Chat :: Help Center :: Sign In :: Sign Out

MY.USTI.NET PORTAL  -  © 1996 - 2004 USTINET CORPORATION. ALL RIGHTS RESERVED.
Please see our Privacy Policy, Security Guarantee, Terms of Use for additional information.